Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1993-04-20
1994-12-06
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4241841, 514 2, 514 23, 514 25, 530412, 530417, 530807, 5361231, A61K 3900, A61K 39116, A61K 39385
Patent
active
053708717
ABSTRACT:
The present invention relates to a vaccine derived from a bacterial or virus product that initially comprises a mixture of polymers of varying molecular weights. The vaccine contains an immunogenically effective polymer comprising T-cell-independent antigen as the effective immunizing agent. The vaccine is free of low molecular weight immunosuppressive antigen-containing polymer as a result of processing of the bacterial or virus product mixture.
REFERENCES:
patent: 3794630 (1974-02-01), Mullan
patent: 3869546 (1975-03-01), Lund
patent: 3919411 (1975-11-01), Glass
patent: 4123520 (1978-10-01), Hagopian et al.
patent: 4140679 (1979-02-01), Malley
patent: 4164565 (1979-08-01), Prince et al.
patent: 4191668 (1980-03-01), Katz
patent: 4220565 (1980-09-01), Katz
patent: 4222907 (1980-09-01), Katz
patent: 4242501 (1980-12-01), Cano et al.
patent: 4253995 (1981-03-01), Katz
patent: 4253996 (1981-03-01), Katz
patent: 4261973 (1981-04-01), Lee
patent: 4276206 (1981-06-01), Katz
patent: 4296097 (1981-10-01), Lee
patent: 4310514 (1982-01-01), Durette
patent: 4388441 (1983-06-01), Katz
patent: 4430260 (1984-02-01), Lee
patent: 4496654 (1985-01-01), Katz
patent: 4673574 (1987-06-01), Anderson et al.
patent: 4874794 (1989-10-01), Katz
patent: 5126131 (1992-06-01), Dintzis
Dintzis, R. Z., et al., PNAS (USA) 79:884-888 (Feb., 1982), "Specific cellular stimulation in the primary immune response: experimental test of a quantized model".
Liu-PNAS 76:1430-1434 (1979).
Feldman, Extracellular Matrix Influences on Gene Expression, p. 467.
Feldman, M., J. of Exp. Med 135:735-752 (1972), "Induction of immunity and tolerance in vitro by hapten protein conjugates".
Brown, Acta Allergologica 31:22 (1976).
Dintzis, H. M., et al., PNAS (USA) 73(10):3671-3675 (Oct., 1976), "Molecular determinants of immunogenicity: the immunon model of immune response".
Chiorazzi, PNAS 73-2091 (1976).
Dintzis, R. Z., et al., J. Immunology 131(5):2196-2203 (Nov., 1983), "Studies on the immunogenicity and tolerogenicity of T-independent antigens".
R. Scopes, Protein Purification (1982), pp. 151-162, Springer-Verlag.
Dintzis, H. M., et al., Theoretical Immunology, part 1:83-102 (1988), "A molecular basis for immune regulation: the immunon hypothesis".
Dintzis, H. M., et al., Immunological Reviews 115:243-251 (1990), "Antigens as immunoregulators".
Dintzis, H. M., et al., P.N.A.S. (USA) 89:1113-1117 (Feb., 1992), "Profound specific suppression by antigen of persistent IgM, IgG, and IgE antibody production".
Dintzis, R. Z., et al., P.N.A.S. (USA) 135(1):423-427 (Jul., 1985), "Inhibition of anti-DNP antibody formation by high doses of DNP-polyacrylamide molecules; effects of hapten density and hapten valence".
Dintzis, R. Z. et al., J. Immunol. 143:1239-1244 (Aug. 15, 1989), "The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence".
Dintzis, R. Z., et al., Eur. J. Immunology 20:229-232 (1990), "Inhibition of antibody formation by receptor cross-linking: the molecular characteristics of inhibitory haptenated polymers".
Porro, M., et al., J. Biological Standardization 11:65-74 (1983), "Immunoelectrophoretic characterization of the molecular weight polydispersion of polysaccharides in multivalent bacterial capsular vaccines".
Dintzis Howard M.
Dintzis Renee Z.
Cunningham Thomas M.
Nucker Christine M.
The Johns Hopkins University
LandOfFree
Therapeutic suppression of specific immune responses by administ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic suppression of specific immune responses by administ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic suppression of specific immune responses by administ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-212912